Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.

about

Focus on five patients treated with cyclosporine up to 62 months.Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

P2860

Q52308590-47283C64-C8AF-4563-BCDE-B971822B2734 Q55020325-C7B78672-FE47-4A76-8990-E1D89F514A04

P2860

Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.

Item

http://www.wikidata.org/entity/Q38061479

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Prolonged cyclosporine treatme ...... dy in a series of 20 patients.

@en

type

Item

label

Prolonged cyclosporine treatme ...... dy in a series of 20 patients.

@en

prefLabel

Prolonged cyclosporine treatme ...... dy in a series of 20 patients.

@en

P1476

Prolonged cyclosporine treatme ...... dy in a series of 20 patients.

@en

P2093

Alberto Maria Bertoldi

http://www.w3.org/2001/XMLSchema#string

Lucia Mantovani

http://www.w3.org/2001/XMLSchema#string

Silvia Giari

http://www.w3.org/2001/XMLSchema#string

P2860

Ciclosporin in psoriasis clinical practice: an international consensus statement.

Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference.

The use of cyclosporine in dermatology: part I.

Clinical outcome evaluation following cyclosporine a treatment in moderate to severe psoriasis: a retrospective study.

Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.

Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure.

Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.

Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.

P304

1512-1516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-4632.2012.05571.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Borghi

Monica Corazza

Annarosa Virgili

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23171021

http://www.w3.org/2001/XMLSchema#string

Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.

about

P2860

P2860

Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698